Alvogen is the next generation pharmaceuticals company. Our business model ensures competitive advantage through focused in-house capabilities and a network of partners for enhanced speed and flexibility. Alvogen currently has commercial operations in 35 countries around the globe, with regional hubs in North America, Romania and Taiwan.

Our passionate team is committed to continue to grow our business around the world and to becoming a top 5 global generic pharmaceuticals player. North America is our largest market with over 60 pending ANDA filings. Other markets include Romania, Hungary, Korea, Taiwan, Bulgaria, Japan, China and Russia.